Published: September 2017 (Web posted June 2017) Read Executive Summary Read Full-Text Guideline This guideline evaluates the following four key questions regarding SBRT inch allenging clinical scenarios in early-stage NSCLC: 1) application of SBRT to operable patients; 2) appropriate use of SBRT in tumors that are centrally located, large, multifocal or unbiopsied, and 3) in individual tailoring of SBRT in “high-risk” clinical scenarios; and 4) SBRT as salvage therapy after recurrence.
Endorsed by:
Key Points:
Resources:
Comparison of the Effectiveness of Radiofrequency Ablation with SBRT in Inoperable Stage I NSCLC (CME) ASTRO’s SBRT Model Policy Patient Brochure
We have recently updated our privacy policy and terms of use. By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use. We use cookies to provide, secure and improve our services to you. To learn more, click here.